Medical devices, healthcare technology and the business of care
DEVICE CATEGORY · PQP

Next Generation Sequencing Oncology Panel, Somatic Or Germline Variant Detection System

A next generation sequencing (NGS) oncology panel is a device used for the qualitative detection of germline or somatic variants in one or more cancer-related genes. The device is intended to be used on DNA or RNA isolated from human clinical specimens.

Product / regulatory recordCompanyPathwayDecision dateSource
Life Technologies CorporationPMA supplementNov 4, 2026FDA
xT CDxP210011/S006
Tempus AI, Inc.PMA supplementOct 23, 2026FDA
MI Cancer SeekP240010/S007
Caris Life SciencesPMA supplementOct 16, 2026FDA
Foundation Medicine, Inc.PMA supplementSep 18, 2026FDA
Guardant360 CDxP200010/S029
Guardant Health, Inc.PMA supplementSep 18, 2026FDA
FoundationOne CDxP170019/S069
Foundation Medicine, Inc.PMA supplementSep 16, 2026FDA
Life Technologies CorporationPMA supplementSep 9, 2026FDA
Guardant360 CDxP200010/S024
Guardant Health, Inc.PMA supplementSep 4, 2026FDA
Illumina, Inc.PMA supplementSep 4, 2026FDA
xT CDxP210011/S002
Tempus AI, Inc.PMA supplementSep 2, 2026FDA
Illumina, Inc.PMA supplementAug 14, 2026FDA
FoundationOne CDxP170019/S064
Foundation Medicine, Inc.PMA supplementAug 12, 2026FDA
Foundation Medicine, Inc.PMA supplementAug 12, 2026FDA
Guardant360 CDxP200010/S032
Guardant Health, Inc.PMA supplementAug 7, 2026FDA
Personal Genome Diagnostics, Inc.PMA approvalJul 30, 2026FDA
Guardant360 CDxP200010/S030
Guardant Health, Inc.PMA supplementJul 14, 2026FDA
Guardant360 CDxP200010/S031
Guardant Health, Inc.PMA supplementJul 6, 2026FDA
Guardant Health, Inc.PMA supplementJul 6, 2026FDA
MI Cancer SeekP240010/S010
Caris Life SciencesPMA supplementJul 2, 2026FDA
Illumina, Inc.PMA supplementJun 26, 2026FDA
Guardant360 CDxP200010/S027
Guardant Health, Inc.PMA supplementJun 10, 2026FDA
Life Technologies CorporationPMA supplementJun 8, 2026FDA
xT CDxP210011/S004
Tempus AI, Inc.PMA supplementMay 28, 2026FDA
MI Cancer SeekP240010/S009
Caris Life SciencesPMA supplementMay 28, 2026FDA
Foundation Medicine, Inc.PMA supplementMay 27, 2026FDA
Foundation Medicine, Inc.PMA supplementMay 27, 2026FDA
Foundation Medicine, Inc.PMA supplementMay 27, 2026FDA
FoundationOne CDxP170019/S065
Foundation Medicine, Inc.PMA supplementMay 27, 2026FDA
Foundation Medicine, Inc.PMA supplementMay 27, 2026FDA
Guardant Health, Inc.PMA approvalMay 19, 2026FDA
Natera, Inc.PMA approvalMay 15, 2026FDA
FoundationOne CDxP170019/S067
Foundation Medicine, Inc.PMA supplementMay 12, 2026FDA
FoundationOne CDxP170019/S059
Foundation Medicine, Inc.PMA supplementMay 8, 2026FDA
Foundation Medicine, Inc.PMA supplementMay 8, 2026FDA
Guardant360 CDxP200010/S025
Guardant Health, Inc.PMA supplementMay 1, 2026FDA
Illumina, Inc.PMA supplementApr 23, 2026FDA
Life Technologies CorporationPMA supplementMar 4, 2026FDA
Guardant360 CDxP200010/S026
Guardant Health, Inc.PMA supplementJan 15, 2026FDA
Guardant360 CDxP200010/S028
Guardant Health, Inc.PMA supplementDec 29, 2025FDA
Life Technologies CorporationPMA supplementNov 21, 2025FDA
Life Technologies CorporationPMA supplementNov 19, 2025FDA
Life Technologies CorporationPMA supplementOct 22, 2025FDA
Life Technologies CorporationPMA supplementOct 15, 2025FDA
Guardant360 CDxP200010/S021
Guardant Health, Inc.PMA supplementSep 25, 2025FDA
Illumina, Inc.PMA supplementSep 19, 2025FDA
Illumina, Inc.PMA supplementSep 5, 2025FDA
Life Technologies CorporationPMA supplementAug 8, 2025FDA
Life Technologies CorporationPMA supplementAug 7, 2025FDA
Life Technologies CorporationPMA approvalJul 2, 2025FDA
Caris Life SciencesPMA approvalNov 5, 2024FDA
Illumina, Inc.PMA approvalAug 21, 2024FDA
xT CDxP210011
Tempus AI, Inc.PMA approvalApr 28, 2023FDA
Foundation Medicine, Inc.PMA approvalAug 26, 2020FDA
Guardant Health, Inc.PMA approvalAug 7, 2020FDA
Foundation Medicine, Inc.PMA approvalNov 30, 2017FDA
Source information

Follow the FDA links to view the original records.

All device categories